4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001104659-26-080009
Director sold 3,553,410 shares at $84.43 ($300,014,406)
- Director acquired 3,553,410 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Fairmount Funds Management LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-01 | Conversion : show line 1 in the form | +3,553,410 | 4,685,364 | I | ||
| 2026-07-01 | Sale : show line 2 in the form | −3,553,410 | $84.43 | $300,014,406 | 1,131,954 | I |
| Open-market sales · 3,553,410 sh · avg $84.43 · $300,014,406 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-01 | Conversion : show line 3 in the form Series B Preferred Stock | −42,641 | 94,497 | I |
Loading xslF345X06/tm2619616-1_4seq1.xml…